Table 1.
Correlates of Preferred Role and Actual Role in Cancer Related Treatment Decision-Making
| Preferred decision role (n, %) | Χ2 test | Actual decision role (n, %) | Χ2 test | |||||
|---|---|---|---|---|---|---|---|---|
| Variables (n) | Active | Collaborative | Passive | p-value | Active | Collaborative | Passive | p-value |
| Total | 342 (37.2) | 324 (49.8) | 84 (12.9) | 311 (47.8) | 194 (29.8) | 145 (22.3) | ||
| Age | ||||||||
| Younger than 50 (202) | 79 (39.1) | 102 (50.5) | 21 (10.4) | 0.417 | 104 (51.5) | 59 (29.2) | 39 (19.3) | 0.362 |
| 50 years old or more (448) | 163 (36.4) | 222 (49.6) | 63 (14.1) | 207 (46.2) | 135 (30.1) | 106 (23.7) | ||
| Age at diagnosis | ||||||||
| 40 years or younger (142) | 59 (41.5) | 66 (46.5) | 17 (12.0) | 0.105 | 69 (48.6) | 36 (25.4) | 37 (26.1) | 0.141 |
| 41-50 (336) | 129 (38.4) | 171 (50.9) | 36 (10.7) | 166 (49.4) | 108 (32.1) | 62 (18.5) | ||
| 51 years or older (172) | 54 (31.4) | 87 (50.6) | 31 (18.0) | 76 (44.2) | 50 (29.1) | 46 (26.7) | ||
| Marital status | ||||||||
| Single (164) | 68 (41.5) | 79 (48.2) | 17 (10.4) | 0.455 | 89 (54.3) | 48 (29.3) | 27 (16.5) | 0.128 |
| Married (466) | 169 (36.3) | 234 (50.2) | 63 (13.5) | 210 (45.1) | 141 (30.3) | 115 (24.7) | ||
| Others (20) | 5 (25.0) | 11 (55.0) | 4 (20.0) | 12 (60.0) | 5 (25.0) | 3 (15.0) | ||
| Education | ||||||||
| High School or less (204) | 86 (42.2) | 88 (43.1) | 30 (14.7) | 0.069 | 95 (46.6) | 54 (26.5) | 55 (27.0) | 0.127 |
| More than High School (446) | 156 (35.0) | 236 (52.9) | 54 (12.1) | 216 (48.4) | 140 (31.4) | 90 (20.2) | ||
| Household income (JPN) | ||||||||
| Less than ¥5,000,000 (279) | 109 (39.1) | 131 (47.0) | 39 (14.0) | 0.75 | 140 (50.2) | 82 (29.4) | 57 (20.4) | 0.207 |
| ¥5,000,000 or more (251) | 91 (36.3) | 131 (52.2) | 29 (11.6) | 122 (48.6) | 67 (26.7) | 62 (24.7) | ||
| Don’t know/ don’t want (120) | 42 (35.0) | 62 (51.7) | 16 (13.3) | 49 (40.8) | 45 (37.5) | 26 (21.7) | ||
| Residential area at diagnosis | ||||||||
| Prefecture 5 million or more people (397) | 151 (38.0) | 200 (50.4) | 46 (11.6) | 0.719 | 195 (49.1) | 121 (30.5) | 81 (20.4) | 0.14 |
| Prefecture less than 5 million people (249) | 90 (36.1) | 122 (49.0) | 37 (14.9) | 112 (45.0) | 73 (29.3) | 64 (25.7) | ||
| Outside the country (4) | 1 (25.0) | 2 (50.0) | 1 (25.0) | 4 (100.0) | 0 (0.0) | 0 (0.0) | ||
| Employment status at diagnosis | ||||||||
| Full-time (192) | 80 (41.7) | 91 (47.4) | 21 (10.9) | 0.587 | 94 (49.0) | 56 (29.2) | 42 (21.9) | 0.729 |
| Contracted/ part-time (210) | 72 (34.3) | 108 (51.4) | 30(14.3) | 95 (45.2) | 70 (33.3) | 45 (21.4) | ||
| Others (248) | 90 (36.3) | 125 (50.4) | 33 (13.3) | 122 (49.2) | 68 (27.4) | 58 (23.4) | ||
| Time since diagnosis | ||||||||
| 5 years or less (321) | 113 (35.2) | 162 (50.5) | 46 (14.3) | 0.423 | 158 (49.2) | 98 (30.5) | 65 (20.2) | 0.46 |
| Longer than 5 years (329) | 129 (39.2) | 162 (49.2) | 38 (11.6) | 153 (46.5) | 96 (29.2) | 80 (24.3) | ||
| Stage of cancer | ||||||||
| 0-II (480) | 184 (38.3) | 239 (49.8) | 57 (11.9) | 0.341 | 239 (49.8) | 148 (30.8) | 93 (19.4) | 0.02 |
| III, IV (74) | 29 (39.2) | 36 (48.6) | 9 (12.2) | 36 (48.6) | 19 (25.7) | 19 (25.7) | ||
| Do not know (96) | 29 (30.2) | 49 (51.0) | 18 (18.8) | 36 (37.5) | 27 (28.1) | 33 (34.4) | ||
| Treatment status | ||||||||
| Undergoing (215) | 82 (38.1) | 103 (47.9) | 30 (14.0) | 0.689 | 114 (53.0) | 60 (27.9) | 41 (19.1) | 0.163 |
| Completed (285) | 99 (34.7) | 148 (51.9) | 38 (13.3) | 121 (42.5) | 91 (31.9) | 73 (25.6) | ||
| Others (150) | 61 (40.7) | 73 (48.7) | 16 (10.7) | 76 (50.7) | 43 (28.7) | 31 (20.7) | ||
| Surgery | ||||||||
| Modified radical mastectomy (248) | 103 (41.5) | 114 (46.0) | 31 (12.5) | 0.114 | 129 (52.0) | 64 (25.8) | 55 (22.2) | 0.192 |
| Breast conserving treatment (382) | 129 (33.8) | 204 (53.4) | 49 (12.8) | 170 (44.5) | 124 (32.5) | 88 (23.0) | ||
| No surgery/ others (20) | 10 (50.0) | 6 (30.0) | 4 (20.0) | 12 (60.0) | 6 (30.0) | 2 (10.0) | ||
| Adjuvant therapy Radiation | ||||||||
| Yes (383) | 137 (35.8) | 196 (51.2) | 50 (13.1) | 0.645 | 173 (45.2) | 116 (30.3) | 94 (24.5) | 0.17 |
| No (267) | 105 (39.3) | 128 (47.9) | 34 (12.7) | 138 (51.7) | 78 (29.2) | 51 (19.1) | ||
| Chemotherapy | ||||||||
| Yes (286) | 107 (37.4) | 140 (49.0) | 39 (13.6) | 0.866 | 135 (47.2) | 80 (28.0) | 71 (24.8) | 0.351 |
| No (364) | 135 (37.1) | 184 (50.5) | 45 (12.4) | 176 (48.4) | 114 (31.3) | 74 (20.3) | ||
| Hormone | ||||||||
| Yes (454) | 169 (37.2) | 227 (50.0) | 58 (12.8) | 0.984 | 219 (48.2) | 137 (30.2) | 98 (21.6) | 0.797 |
| No (196) | 73 (37.2) | 97 (49.5) | 26 (13.3) | 92 (46.9) | 57 (29.1) | 47 (24.0) | ||